Copyright © 2012 Aleksandra Szczawinska-Poplonyk. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. P. A. Velilla, M. T. Rugeles, and C. A. Chougnet, “Defective antigen-presenting cell function in human neonates,” Clinical Immunology, vol. 121, no. 3, pp. 251–259, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
2. F. Saito, H. Kuwata, E. Oiki et al., “Inefficient phagosome maturation in infant macrophages,” Biochemical and Biophysical Research Communications, vol. 375, no. 1, pp. 113–118, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
3. C. Härtel, N. Adam, T. Strunk, P. Temming, M. Müller-Steinhardt, and C. Schultz, “Cytokine responses correlate differentially with age in infancy and early childhood,” Clinical and Experimental Immunology, vol. 142, no. 3, pp. 446–453, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
4. S. Hodge, G. Hodge, R. Flower, and P. Han, “Cord blood leucocyte expression of functionally significant molecules involved in the regulation of cellular immunity,” Scandinavian Journal of Immunology, vol. 53, no. 1, pp. 72–78, 2001. View at Publisher · View at Google Scholar · View at Scopus
5. B. Morein, G. Blomqvist, and K. Hu, “Immune responsiveness in the neonatal period,” Journal of Comparative Pathology, vol. 137, no. 1, pp. S27–S31, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
6. A. Gasparoni, L. Ciardelli, A. Avanzini et al., “Age-related changes in intracellular Th1/Th2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults,” Biology of the Neonate, vol. 84, no. 4, pp. 297–303, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
7. A. Kotiranta-Ainamo, J. Rautonen, and N. Rautonen, “Imbalanced cytokine secretion in newborns,” Biology of the Neonate, vol. 85, no. 1, pp. 55–60, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
8. B. Adkins, “Heterogeneity in the CD4 T cell compartment and the variability of neonatal immune responsiveness,” Current Immunology Reviews, vol. 3, no. 3, pp. 151–159, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
9. M. Belderbos, O. Levy, and L. Bont, “Neonatal innate immunity in allergy development,” Current Opinion in Pediatrics, vol. 21, no. 6, pp. 762–769, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
10. N. W. J. Schröder, “The role of innate immunity in the pathogenesis of asthma,” Current Opinion in Allergy and Clinical Immunology, vol. 9, no. 1, pp. 38–43, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
11. V. Moschese, S. Graziani, M. A. Avanzini et al., “A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network,” International Journal of Immunopathology and Pharmacology, vol. 21, no. 2, pp. 343–352, 2008. View at Scopus
12. N. Kutukculer and N. Gulez, “The outcome of patients with unclassified hypogammaglobulinemia in early childhood,” Pediatric Allergy and Immunology, vol. 20, no. 7, pp. 693–698, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
13. S. Keles, H. Artac, R. Kara, B. Gokturk, A. Ozen, and I. Reisli, “Transient hypogammaglobulinemia and unclassified hypogammaglobulinemia: similarities and differences,” Pediatric Allergy and Immunology, vol. 21, no. 5, pp. 843–851, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
14. T. Klemola, “Deficiency of immunoglobulin A,” Annals of Clinical Research, vol. 19, no. 4, pp. 248–257, 1987. View at Scopus
15. B. R. Ludviksson, T. H. Eiriksson, B. Ardal, A. Sigfusson, and H. Valdimarsson, “Correlation between serum immunoglobulin A concentrations and allergic manifestations in infants,” Journal of Pediatrics, vol. 121, no. 1, pp. 23–27, 1992. View at Publisher · View at Google Scholar · View at Scopus
16. B. R. Luovíksson, G. J. Arason, O. Thorarensen, B. Árdal, and H. Valdimarsson, “Allergic diseases and asthma in relation to serum immunoglobulins and salivary immunoglobulin A in pre-school children: a follow-up community-based study,” Clinical and Experimental Allergy, vol. 35, no. 1, pp. 64–69, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
17. A. Papadopoulou, D. Mermiri, S. Taousani, M. Triga, P. Nicolaidou, and K. N. Priftis, “Bronchial hyper-responsiveness in selective IgA deficiency,” Pediatric Allergy and Immunology, vol. 16, no. 6, pp. 495–500, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
18. N. Kutukculer, N. E. Karaca, O. Demircioglu, and G. Aksu, “Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency,” Pediatric Allergy and Immunology, vol. 18, no. 2, pp. 167–173, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
19. A. Aghamohammadi, T. Cheraghi, M. Gharagozlou et al., “IgA deficiency: correlation between clinical and immunological phenotypes,” Journal of Clinical Immunology, vol. 29, no. 1, pp. 130–136, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
20. C. De Moraes Lui, L. C. Oliveira, C. L. Diogo, M. Kirschfink, and A. S. Grumach, “Immunoglobulin G subclass concentrations and infections in children and adolescents with severe asthma,” Pediatric Allergy and Immunology, vol. 13, no. 3, pp. 195–202, 2002. View at Publisher · View at Google Scholar · View at Scopus
21. M. F. Goldstein, A. L. Goldstein, E. H. Dunsky, D. J. Dvorin, G. A. Belecanech, and K. Shamir, “Pediatric selective IgM immunodeficiency,” Clinical and Developmental Immunology, vol. 2008, Article ID 624850, 10 pages, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
22. L. Yel, S. Ramanuja, and S. Gupta, “Clinical and immunological features in igm deficiency,” International Archives of Allergy and Immunology, vol. 150, no. 3, pp. 291–298, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
23. M. S. Shabestari and N. Rezaei, “Asthma and allergic rhinitis in a patient with BTK deficiency,” Journal of Investigational Allergology and Clinical Immunology, vol. 18, no. 4, pp. 300–304, 2008. View at Scopus
24. N. Rezaei, A. Aghamohammadi, G. A. Kardar, M. Nourizadeh, and Z. Pourpak, “T- helper 1 and 2 cytokine assay in patients with common variable immunodeficiency,” Journal of Investigational Allergology and Clinical Immunology, vol. 18, no. 6, pp. 449–453, 2008. View at Scopus
25. P. R. Ogershok, M. B. Hogan, J. E. Welch, W. T. Corder, and N. W. Wilson, “Spectrum of illness in pediatric common variable immunodeficiency,” Annals of Allergy, Asthma and Immunology, vol. 97, no. 5, pp. 653–656, 2006. View at Scopus
26. S. M. Drouin, D. B. Corry, J. Kildsgaard, and R. A. Wetsel, “Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy,” Journal of Immunology, vol. 167, no. 8, pp. 4141–4145, 2001. View at Scopus
27. D. M. Walters, P. N. Breysse, B. Schofield, and M. Wills-Karp, “Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness,” American Journal of Respiratory Cell and Molecular Biology, vol. 27, no. 4, pp. 413–418, 2002. View at Scopus
28. J. Köhl, R. Baelder, I. P. Lewkowich et al., “A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 783–796, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. J. Köhl and M. Wills-Karp, “Complement regulates inhalation tolerance at the dendritic cell/T cell interface,” Molecular Immunology, vol. 44, no. 1–3, pp. 44–56, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
30. H. K. Thórarinsdóttir, B. R. Lúdvíksson, T. Víkingsdóttir et al., “Childhood levels of immunoglobulins and mannan-binding lectin in relation to infections and allergy,” Scandinavian Journal of Immunology, vol. 61, no. 5, pp. 466–474, 2005. View at Publisher · View at Google Scholar · View at PubMed
31. A. Nagy, G. T. Kozma, M. Keszei, A. Treszl, A. Falus, and C. Szalai, “The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin,” Journal of Allergy and Clinical Immunology, vol. 112, no. 4, pp. 729–734, 2003. View at Publisher · View at Google Scholar · View at Scopus
32. J. Aittoniemi, H. Soranummi, A. T. Rovio et al., “Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults,” Clinical and Experimental Immunology, vol. 142, no. 1, pp. 120–124, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
33. X. L. Zhang and M. A. M. Ali, “Ficolins: structure, function and associated diseases,” Advances in Experimental Medicine and Biology, vol. 632, pp. 105–115, 2008. View at Scopus
34. M. Cedzynski, A. P. M. Atkinson, A. S. Swierzko et al., “L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children,” Molecular Immunology, vol. 47, no. 2-3, pp. 415–419, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
35. A. M. Fitzpatrick, F. Holguin, W. G. Teague, and L. A. S. Brown, “Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma,” Journal of Allergy and Clinical Immunology, vol. 121, no. 6, pp. 1372–1378.e3, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
36. A. Varin, S. Mukhopadhyay, G. Herbein, and S. Gordon, “Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion,” Blood, vol. 115, no. 2, pp. 353–362, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
37. L. F. Lu and A. Rudensky, “Molecular orchestration of differentiation and function of regulatory T cells,” Genes and Development, vol. 23, no. 11, pp. 1270–1282, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
38. A. Corthay, “How do regulatory t cells work?” Scandinavian Journal of Immunology, vol. 70, no. 4, pp. 326–336, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
39. N. Cools, P. Ponsaerts, V. F. I. Van Tendeloo, and Z. N. Berneman, “Regulatory T cells and human disease,” Clinical and Developmental Immunology, vol. 2007, Article ID 89195, 10 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
40. S. Nandakumar, C. W. T. Miller, and U. Kumaraguru, “T regulatory cells: an overview and intervention techniques to modulate allergy outcome,” Clinical and Molecular Allergy, vol. 7, article no. 5, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
41. S. Finotto, “T-cell regulation in asthmatic diseases,” Chemical Immunology and Allergy, vol. 94, pp. 83–92, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
42. O. Palomares, G. Yaman, A. K. Azkur, T. Akkoc, M. Akdis, and C. A. Akdis, “Role of Treg in immune regulation of allergic diseases,” European Journal of Immunology, vol. 40, no. 5, pp. 1232–1240, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
43. C. A. Akdis and M. Akdis, “Mechanisms and treatment of allergic disease in the big picture of regulatory T cells,” Journal of Allergy and Clinical Immunology, vol. 123, no. 4, pp. 735–746, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
44. M. Akdis, K. Blaser, and C. A. Akdis, “T regulatory cells in allergy,” Chemical Immunology and Allergy, vol. 91, pp. 159–173, 2006. View at Scopus
45. F. Meiler, S. Klunker, M. Zimmermann, C. A. Akdis, and M. Akdis, “Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors,” Allergy, vol. 63, no. 11, pp. 1455–1463, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
46. D. Hartl, M. Griese, T. Nicolai et al., “Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough,” Journal of Allergy and Clinical Immunology, vol. 115, no. 4, pp. 728–736, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
47. H. Saito, “Essentials for starting a pediatric clinical study (2): role of environment and immunity in the development of childhood allergic and immunologic disorders,” Journal of Toxicological Sciences, vol. 34, no. 2, pp. SP313–SP319, 2009. View at Publisher · View at Google Scholar · View at Scopus
48. A. S. Adamson, K. Collins, A. Laurence, and J. J. O'Shea, “The Current STATus of lymphocyte signaling: new roles for old players,” Current Opinion in Immunology, vol. 21, no. 2, pp. 161–166, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
49. M. Jutel and C. A. Akdis, “T-cell subset regulation in atopy,” Current Allergy and Asthma Reports, vol. 11, no. 2, pp. 139–145, 2011. View at Publisher · View at Google Scholar · View at PubMed
50. S. Trifari and H. Spits, “IL-22-producing CD4+ T cells: Middle-men between the immune system and its environment,” European Journal of Immunology, vol. 40, no. 9, pp. 2369–2371, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
51. H. J. J. Van Der Vliet and E. E. Nieuwenhuis, “IPEX as a result of mutations in FOXP3,” Clinical and Developmental Immunology, vol. 2007, Article ID 89017, 5 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
52. J. Genre, P. R. Errante, C. M. Kokron, M. Toledo-Barros, N. O. S. Câmara, and L. V. Rizzo, “Reduced frequency of CD4⁺$\text{CD}{25}^{\text{HIGH}}$FOXP3⁺ cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity?” Clinical Immunology, vol. 132, no. 2, pp. 215–221, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
53. K. M. Melo, K. I. Carvalho, F. R. Bruno et al., “A decreased frequency of regulatory T cells in patients with common variable immunodeficiency,” PLoS One, vol. 4, no. 7, Article ID e6269, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
54. S. M. Holland, F. R. DeLeo, H. Z. Elloumi et al., “STAT3 mutations in the hyper-IgE syndrome,” New England Journal of Medicine, vol. 357, no. 16, pp. 1608–1619, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
55. J. D. Milner, J. M. Brenchley, A. Laurence et al., “Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome,” Nature, vol. 452, no. 7188, pp. 773–776, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
56. K. R. Engelhardt, S. McGhee, S. Winkler et al., “Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome,” Journal of Allergy and Clinical Immunology, vol. 124, no. 6, pp. 1289–1302.e4, 2009. View at Publisher · View at Google Scholar · View at PubMed
57. Y. Minegishi, M. Saito, T. Morio et al., “Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity,” Immunity, vol. 25, no. 5, pp. 745–755, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
58. T. Kawai and S. Akira, “The roles of TLRs, RLRs and NLRs in pathogen recognition,” International Immunology, vol. 21, no. 4, pp. 317–337, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
59. I. Bekeredjian-Ding and G. Jego, “Toll-like receptors—sentries in the B-cell response,” Immunology, vol. 128, no. 3, pp. 311–323, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
60. N. Novak, T. Bieber, and W. M. Peng, “The immunoglobulin E-toll-like receptor network,” International Archives of Allergy and Immunology, vol. 151, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
61. S. J. Galli and M. Tsai, “Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity,” European Journal of Immunology, vol. 40, no. 7, pp. 1843–1851, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
62. V. Kumar and A. Sharma, “Mast cells: emerging sentinel innate immune cells with diverse role in immunity,” Molecular Immunology, vol. 48, no. 1–3, pp. 14–25, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
63. M. Yoshioka, N. Fukuishi, S. Iriguchi et al., “Lipoteichoic acid downregulates FcεRI expression on human mast cells through Toll-like receptor 2,” Journal of Allergy and Clinical Immunology, vol. 120, no. 2, pp. 452–461, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
64. N. Novak, J. P. Allam, T. Hagemann et al., “Characterization of FcεRI-bearing CD123⁺ blood dendritic cell antigen-2⁺ plasmacytoid dendritic cells in atopic dermatitis,” Journal of Allergy and Clinical Immunology, vol. 114, no. 2, pp. 364–370, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
65. V. P. Walker and R. L. Modlin, “The vitamin D connection to pediatric infections and immune function,” Pediatric Research, vol. 65, no. 5, pp. 106R–113R, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
66. N. E. Lange, A. Litonjua, C. M. Hawrylowicz, and S. Weiss, “Vitamin D, the immune system and asthma,” Expert Review of Clinical Immunology, vol. 5, no. 6, pp. 693–702, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
67. M. S. Sandhu and T. B. Casale, “The role of vitamin D in asthma,” Annals of Allergy, Asthma and Immunology, vol. 105, no. 3, pp. 191–199, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
68. M. Gereke, S. Jung, J. Buer, and D. Bruder, “Alveolar type II epithelial cells present antigen to CD4+ T cells and induce Foxp3+ regulatory T cells,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 5, pp. 344–355, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
69. C. A. Camargo Jr., S. L. Rifas-Shiman, A. A. Litonjua et al., “Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age,” American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 788–795, 2007. View at Scopus
70. G. Devereux, A. A. Litonjua, S. W. Turner et al., “Maternal vitamin D intake during pregnancy and early childhood wheezing,” American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 853–859, 2007. View at Scopus
71. J. M. Brehm, J. C. Celedón, M. E. Soto-Quiros et al., “Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 9, pp. 765–771, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus